Diabetes Mellitus and Hypertension as Major Risk Factors of Mortality From Covid-19 Pneumonia

Vasileios Petrakis; Periklis Panagopoulos; Dimitrios Papazoglou; Nikolaos Papanas

doi:10.1055/a-1325-0381

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2022; 130(03): 205-206
DOI: 10.1055/a-1325-0381

Letter to the Editor

Diabetes Mellitus and Hypertension as Major Risk Factors of Mortality From Covid-19 Pneumonia

Vasileios Petrakis

¹Department of Infectious Diseases, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

,

Periklis Panagopoulos

¹Department of Infectious Diseases, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

,

Dimitrios Papazoglou

¹Department of Infectious Diseases, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

²Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

,

Nikolaos Papanas

²Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

› Author Affiliations

Abstract

Full Text

References

References
1 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5: 536-544
2 World Health Organization WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020, 2020. Available https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020. Last accessed: 10th October 2020
3 Li H, Liu SM, Yu XH. et al. Coronavirus disease 2019 (COVID-19): Current status and future perspectives. Int J Antimicrob Agents 2020; 55: 105951
4 Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008; 88: 1254-1264
5 World Health Organization (WHO) Diabetes country profiles. 2016; https://www.who.int/diabetes/country-profiles/grc_en.pdf?ua=1, Last accessed 12th November 2020;
6 Pititto BA, Ferreira SRG. Diabetes and Covid-19: More than the sum of two morbidities. Rev Saude Publica 2020; 54: 54
7 Guan W, Ni Z, Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N Eng J Med 2020; 382: 1708-1720
8 Grasselli G, Zangrillo A, Zanella A. et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 323: 1574-1581
9 Garg S, Kim L, Whitaker M. et al. Hospitalized rates and characteristics of patients with laboratory-confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 458-464
10 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395: 1054-1062
11 Papachristou S, Penlioglou T, Stoian AP. et al. COVID-19 and sodium-glucose cotransporter 2 inhibitors: No fear to attempt? Exp Clin Endocrinol Diabetes. 2020; Sep 10. Online ahead of print
12 Penlioglou T, Papachristou S, Papanas N. COVID-19 and diabetes mellitus: may old anti-diabetic agents become the new philosopher’s stone?. Diabetes Ther 2020; 11: 1-3